Ligand validation:9JFN

AG2: AGMATINE

AG2 is a Ligand Of Interest in 9JFN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9JFN_AG2_E_601	90%	73%	0.072	0.953	0.56	0.48	-	-	0	0	100%	1
9JFN_AG2_F_601	89%	71%	0.076	0.954	0.6	0.51	-	-	0	0	100%	1
9JFN_AG2_H_601	88%	78%	0.076	0.951	0.51	0.38	-	-	0	0	100%	1
9JFN_AG2_G_601	88%	73%	0.077	0.951	0.55	0.5	-	-	0	0	100%	1
9JF5_AG2_G_601	96%	75%	0.056	0.966	0.58	0.41	-	-	1	0	100%	1
8ASZ_AG2_A_401	97%	5%	0.058	0.972	2.34	3.01	3	2	0	0	100%	1
4XQG_AG2_B_505	72%	39%	0.12	0.943	1.89	0.54	2	-	0	0	100%	1
6AGG_AG2_Z_503	66%	25%	0.108	0.911	2.03	1.06	1	1	4	0	100%	1
7LOL_AG2_A_401	60%	20%	0.131	0.915	2.5	0.94	3	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.